The quality of medication information in Australia: The need for more clinical expertise and accountability

Medical Journal of Australia

Volumn 190, Issue 3, 2009, Pages 110-111

  Stockigt, Jim R ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL INSUFFICIENCY; AUSTRALIA; CONSUMER HEALTH INFORMATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; EVIDENCE BASED PRACTICE; GOVERNMENT REGULATION; HEALTH PRACTITIONER; MEDICAL ETHICS; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL PROFESSION; PHARMACEUTICAL CARE; PRESCRIPTION; PROFESSIONAL PRACTICE; QUALITY CONTROL;

EID: 61349124900     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2009.tb02306.x     Document Type: Editorial

References (11)

1. Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Second discussion paper: improving access to consumer medicines information (CMI) and product information (PI). Canberra: Australian Government, 2007. http://www.tga.gov.au/meds/accesspmi2.htm (accessed Nov 2008).
2. Stockigt JR. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications. Med J Aust 2007; 186: 76-79.
3. Endocrine Society of Australia. Position statement. Prescribing information (PI) and consumer medicine information (CMI). http://www.endocrinesociety.org.au/posstat_Cmi.htm (accessed Nov 2008).
4. Stockigt JR, Torpy DJ, Fuller PJ, et al. Consumer medicine information (CMI) for glucocorticoid replacement medications one year on: unsafe errors persist. Melbourne: Endocrine Society of Australia, 2008. http://www.endocrinesociety.org.au/Glucocorticoids_unsafe_CMI_paper.pdf (accessed Nov 2008).
5. Stockigt JR. Summary of on-line consumer medicine information for the glucocorticoid replacement medications, Cortate and Hysone. Melbourne: Endocrine Society of Australia, 2008. http://www.endocrinesociety.org.au/ Glucocorticoids_online_CMI_sources.pdf (accessed Nov 2008).
6. MIMS online. Product information for thyroxine, liothyronine, carbimazole and propylthiouracil. http://mims.hcn.net.au/ifmx-nsapi/ mims-data/?Mlval=2MIMS_ssearchMIMS (accessed Nov 2008).
7. Hammett R. Response from TGA to Australian Prescriber (received 05 Aug, 2008). Consumer Medicine Information for glucocorticoid replacement medications 1 year on - a reply to Professor Stockigt and others. Australian Addisons Disease Association, 2008. http://www.addisons.org.au/core.htm (Content, News and Media) (accessed Nov 2008).
8. Weekes L. Bid to clarify drug information. The Australian 2008; 30 Aug. http://www.theaustralian.news.com.au/story/0,24257150-23289,00.html (accessed Nov 2008).
9. Donohoo EA. Misleading advertising of Pl-based drug information [letter]. Med J Aust 2008; 188: 679-680.
10. Dowden JS. Product information past perfect. Med J Aust 2007; 186: 51-52.
11. Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Regulatory reforms common to all product sectors. Consultation on regulatory reforms July/August 2008. http://www.tga.gov.au/regreform/common.htm (accessed Nov 2008).